Allopurinol Counteracts Inadequate Mercaptopurine Metabolism in Paediatric Acute Lymphoblastic Leukemia

被引：0
|
作者：
De Beaumais, T. Adam [1 ]
Petit, A. [2 ]
Simonin, M. [2 ]
Medard, Y. [1 ]
Benchikh, A. [1 ]
Dollfus, C. [2 ]
Leverger, G. [2 ]
Jacqz-Aigrain, E. [1 ]
机构：
[1] Robert Debre Hosp, AP HP, Pediat Pharmacol & Pharmacogenet, Paris, France
[2] Trousseau Hosp, AP HP, Pediat Hematol & Oncol, Paris, France
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V152 SIOP1
引用
收藏
页码：S238 / S239
页数：2
相关论文
共 50 条
  • [21] ADHERENCE TO MERCAPTOPURINE AND HABIT STRENGTH IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
    Yang, Mira
    Singh, Revika
    King, Kathryn
    Badawy, Sherif
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S59 - S60
  • [22] Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia
    de Beaumais, Tiphaine Adam
    Jacqz-Aigrain, Evelyne
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (09) : 1233 - 1242
  • [23] Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and Lymphoma during maintenance therapy
    Barone, Tecca
    Dandekar, Smita
    Mckeone, Daniel
    Mulieri, Kevin
    CANCER REPORTS, 2024, 7 (02)
  • [24] Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL)
    Stuckert, Austin J.
    Schafer, Eric S.
    Bernhardt, M. Brooke
    Baxter, Patricia
    Brackett, Julienne
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1246 - 1249
  • [25] VARIABLE MERCAPTOPURINE METABOLISM AND TREATMENT OUTCOME IN CHILDHOOD LYMPHOBLASTIC-LEUKEMIA
    LENNARD, L
    LILLEYMAN, JS
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) : 1816 - 1823
  • [26] Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia
    Stocco, G.
    Cheok, M. H.
    Crews, K. R.
    Dervieux, T.
    French, D.
    Pei, D.
    Yang, W.
    Cheng, C.
    Pui, C-H
    Relling, M. V.
    Evans, W. E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (02) : 164 - 172
  • [27] Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia
    Alsous, Mervat
    Abu Farha, Rana
    Alefishat, Eman
    Al Omar, Suha
    Momani, Deema
    Gharabli, Alia
    McElnay, James
    Horne, Robert
    Rihani, Rawad
    PLOS ONE, 2017, 12 (09):
  • [28] Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia
    Lau, RCW
    Matsui, D
    Greenberg, M
    Koren, G
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 30 (02): : 85 - 90
  • [29] CELLULAR PHARMACOLOGY OF 6-MERCAPTOPURINE IN ACUTE LYMPHOBLASTIC-LEUKEMIA
    BOSTROM, B
    ERDMANN, G
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1993, 15 (01): : 80 - 86
  • [30] BIOCHEMICAL PARAMETERS OF MERCAPTOPURINE ACTIVITY IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    ZIMM, S
    REAMAN, G
    MURPHY, RF
    POPLACK, DG
    CANCER RESEARCH, 1986, 46 (03) : 1495 - 1498
12345